Optimal positioning of self‐expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement

Objectives To evaluate the association between measurements performed during Medtronic CoreValve (MCV) deployment and paravalvular leak (PVL). Background The MCV can be recaptured and repositioned, allowing the TAVR operator to implant at a more favorable position. The association between angiograph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2019-01, Vol.93 (1), p.149-155
Hauptverfasser: Dadu, Razvan T., Xu, Jiaqiong, Rehman, Hasan, Ballmoos, Moritz Wyler, Barker, Colin M., Reyes, Manuel, Ramchandani, Mahesh, Reul, Ross M., Reardon, Michael J., Kleiman, Neal S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To evaluate the association between measurements performed during Medtronic CoreValve (MCV) deployment and paravalvular leak (PVL). Background The MCV can be recaptured and repositioned, allowing the TAVR operator to implant at a more favorable position. The association between angiographic measurements of MCV position while the valve is recapturable and PVL post deployment has not been investigated. Methods 493 patients undergoing TAVR with MCV (January 2011–July 2017) were included. PVL was defined as intraprocedural aortic regurgitation that was judged clinically to require balloon postdilation. Depth of the valve at the left coronary cusp (LCC) and noncoronary cusp (NCC) were measured when the valve was 80% deployed. An optimal cutoff value for the ratio LCC/NCC for PVL was identified in 40 patients. Using this cutoff value, the association between LCC/NCC and PVL was then validated in 453 patients. Results The median LCC/NCC was 1.51 (interquartile range 1.06–1.89).The optimal cutoff value for LCC/NCC was 1.48 (93% sensitivity, 77% specificity, AUC0.85). In the validation group 112 (24.7%) patients had PVL. For LCC/NCC ≥ 1.48, the incidence of PVL was lower compared to LCC/NCC < 1.48 (9.58% vs. 41.78%, P < 0.0001). LCC/NCC of 1.48 had a sensitivity of 79.5% and specificity of 63.6% for PVL (AUC0.72). In a multivariate model, LCC/NCC < 1.48 independently predicted PVL (OR = 6.67, 95% CI 3.96–11.23, P < 0.0001). Conclusion Positioning the MCV such that the LCC/NCC is ≥1.48 may result in less PVL.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.27829